What is ECOR's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.09B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for ECOR?

P/E (TTM) is n/a and 52-week range is $4.41 to $12.70 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s ECOR figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for ECOR?

The company profile lists revenue (TTM) near $35M, net income (TTM) near $-1.42B, EPS (TTM) near $-1.66 when available from the market-data feed. Figures are informational and may lag live markets.

Where is electroCore, Inc. based, and what identifiers does Chartloom list?

The company context section lists headquarters in Rockaway, New Jersey, US, 9M shares outstanding, ISIN US28531P2020 when available from company profile and filing metadata.

Chartloom

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. The company is headquartered in Rockaway, New Jersey and currently employs 83 full-time employees. The company went IPO on 2018-06-22. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

Employees

Website

www.electrocore.com/

IPO

2018-06-22

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)